SFLT1 (SOLUBLE FMS-LIKE TYROSINE KINASE-1) / SERUM

image not found

NABL Cap Accredited    
The SFLT1 test measures levels of soluble fms-like tyrosine kinase-1, a key anti-angiogenic biomarker involved in regulating placental blood vessel development. Elevated SFLT1 levels are associated with placental dysfunction and an increased risk of preeclampsia. This test helps clinicians evaluate pregnancy complications early and supports timely clinical decision-making. Metropolis Healthcare performs this serum-based assay using advanced immunoassay technology for precise and reliable results

  • 17 Crores+ Samples Processed
  • World Class Technology Labs
  • 25+ Years of Trust & Experience
  • Free Home Collection

Price: Rs. 4,030.00

Sample Type: SERUM

Fasting Not Required


Notes: S0547

Frequently Asked Questions (FAQ's):

What does the SFLT1 test measure?
It measures soluble FMS-like tyrosine kinase-1 to assess placental health and angiogenic balance.

Why is SFLT1 important in pregnancy?
High SFLT1 levels can indicate placental stress and a higher risk of preeclampsia.

How is the test useful?
It helps in early detection, risk assessment, and monitoring of pregnancy-related hypertensive disorders.

Do I need to fast before the test?
No fasting or special preparation is required.

What sample is required?
A serum sample obtained from a routine blood draw.

Is this test done alone?
It is often paired with PLGF to calculate the SFLT1/PLGF ratio for better prediction of preeclampsia.

How does Metropolis Healthcare conduct this test?
Metropolis Healthcare uses high-sensitivity immunoassays to ensure accurate quantification.

Can the test be repeated for monitoring?

Yes, repeat testing helps track changes in placental function over time 

OUR corporates PARTNER

Feedback

Patient's Testimonials

Trusted by Thousands

OUR Accreditations

OUR Lab